Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

2.56
-0.0300-1.16%
Post-market: 2.610.0500+1.95%19:30 EDT
Volume:1.82M
Turnover:4.68M
Market Cap:281.02M
PE:-15.06
High:2.66
Open:2.64
Low:2.53
Close:2.59
52wk High:5.45
52wk Low:2.51
Shares:109.77M
Float Shares:85.39M
Volume Ratio:0.87
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:0.76
PE(LYR):-1.27

Loading ...

Quince Therapeutics Names Brigette Roberts CEO in Management Reshuffle

Reuters
·
Aug 01

Rocket Pharmaceuticals Principal Accounting Officer Joseph Manhede Files Initial Beneficial Ownership Statement

Reuters
·
Jul 09

Rocket Pharma Names Joseph Manhede Principal Accounting Officer, Effective July 8

Reuters
·
Jul 01

Rocket Pharmaceuticals sells rare pediatric disease priority review voucher for $180 million

Reuters
·
Jun 12

Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million

THOMSON REUTERS
·
Jun 12

Bank of America Securities Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Jun 11

Rocket Pharmaceuticals price target raised to $10 from $9 at BofA

TIPRANKS
·
Jun 03

Bank of America Securities Sticks to Its Buy Rating for Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Jun 03

Rocket Pharma to present at Jefferies Global Healthcare Conference

Reuters
·
May 28

Rocket Pharma CEO Gaurav Shah sells 55,684 shares for $171,787.82

Reuters
·
May 27

Rocket Pharmaceuticals shareholders approve stock option exchange program at annual meeting

Reuters
·
May 21

Rocket Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
May 11

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 11

Rocket Pharmaceuticals' Cardiac Programs Updates to Offer 'Strong' Share Price Catalysts, Wedbush Says

MT Newswires Live
·
May 09

Wedbush Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Artivion (AORT) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 08

Rocket Pharmaceuticals Q1 EPS $(0.42) Beats $(0.43) Estimate

Benzinga Earnings
·
May 08

Rocket Pharma Q1 net loss narrows to $47.6 million; R&D expenses fall to $31.5 million

Reuters
·
May 08

Rocket Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
May 04

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI)

TIPRANKS
·
Apr 29